Literature DB >> 4630232

Comparative study of tobramycin and gentamicin with special reference to anti-pseudomonas activity.

J Klastersky, D Daneau, V de Maertelaer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4630232     DOI: 10.1002/cpt1973141104

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  6 in total

1.  Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.

Authors:  M I Marks; S Hammerberg; G Greenstone; B Silver
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

Review 2.  Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

3.  Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.

Authors:  K E Price; T A Pursiano; M D DeFuria
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

4.  Aminoglycoside cross-resistance patterns of gentamicin-resistant bacteria.

Authors:  E T Houang; D Greenwood
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

5.  Comparative clinical study of tobramycin and gentamicin.

Authors:  J Klastersky; C Hensgens; A Henri; D Daneau
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

6.  Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.

Authors:  A V Reynolds; J M Hamilton-Miller; W Brumfitt
Journal:  Br Med J       Date:  1974-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.